Investor Frazier Life Sciences Public Fund, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Frazier Life Sciences Public Fund, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-09-17 13D/A HLVX / HilleVax, Inc. 10,639,562 0
2025-08-20 13D/A MBX / MBX Biosciences, Inc. 5,985,347 4,557,097
2025-08-20 13D/A KALV / KalVista Pharmaceuticals, Inc. 4,887,867 2,400,276
2025-08-20 13D/A PHAT / Phathom Pharmaceuticals, Inc. 14,429,990 5,985,327
2025-08-14 13G/A XLO / Xilio Therapeutics, Inc. 5,747,193 8,141,017
2025-08-14 13G/A JBIO / Jade Biosciences, Inc. 1,772,116 1,340,703
2025-08-14 13G/A AURA / Aura Biosciences, Inc. 6,315,678 3,113,550
2025-08-14 13G/A MAZE / Maze Therapeutics, Inc. 4,451,339 3,352,915
2025-08-14 13G/A PVLA / Palvella Therapeutics, Inc. 690,012 545,504
2025-08-14 13G/A LXEO / Lexeo Therapeutics, Inc. 5,500,812 3,073,467
2025-08-14 13G/A MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) 40,349,315 32,430,690
2025-08-14 13G/A SVRA / Savara Inc. 11,462,301 6,745,296
2025-08-14 13G/A IRON / Disc Medicine, Inc. 1,754,834 1,026,489
2025-08-14 13G/A ERAS / Erasca, Inc. 22,575,851 15,038,753
2025-08-14 13G/A ELEV / Elevation Oncology, Inc. 5,993,579 0
2025-08-14 13G/A ADVM / Adverum Biotechnologies, Inc. 10,416,666 1,129,057
2025-08-14 13G/A MGNX / MacroGenics, Inc. 3,175,665 1,549,193
2025-06-12 13G XLO / Xilio Therapeutics, Inc. 5,747,193
2025-06-04 13G LXEO / Lexeo Therapeutics, Inc. 5,500,812
2025-05-23 13G AURA / Aura Biosciences, Inc. 6,315,678
2025-05-15 13G/A TRVI / Trevi Therapeutics, Inc. 10,664,774 10,259,409
2025-05-15 13G/A SVRA / Savara Inc. 8,660,379 11,462,301
2025-05-15 13G/A ERAS / Erasca, Inc. 16,216,216 22,575,851
2025-05-15 13G/A ORIC / ORIC Pharmaceuticals, Inc. 4,142,855 1,410,193
2025-05-15 13G/A PVLA / Palvella Therapeutics, Inc. 575,892 690,012
2025-05-13 13D/A PHAT / Phathom Pharmaceuticals, Inc. 12,788,710 14,429,990
2025-05-05 13G JBIO / Jade Biosciences, Inc. 1,772,116
2025-04-29 13G/A MAZE / Maze Therapeutics, Inc. 3,193,900 4,451,339
2025-04-29 13G/A MAZE / Maze Therapeutics, Inc. 3,193,900 4,129,000
2025-04-04 13G MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) 40,349,315
2025-02-14 13G/A ANAB / AnaptysBio, Inc. 1,917,191 463,241
2025-02-14 13G/A ANAB / AnaptysBio, Inc. 1,917,191 1,655,295
2025-02-14 13G/A ELDN / Eledon Pharmaceuticals, Inc. 3,561,644 1,176,735
2025-02-14 13G/A TRVI / Trevi Therapeutics, Inc. 7,381,090 10,664,774
2025-02-14 13G/A PBYI / Puma Biotechnology, Inc. 2,631,713 0
2025-02-14 13G/A ANTX / AN2 Therapeutics, Inc. 0
2025-02-10 13G MAZE / Maze Therapeutics, Inc. 3,193,900
2025-01-08 13G PVLA / Palvella Therapeutics, Inc. 575,892
2024-11-27 13G SVRA / Savara Inc. 8,660,379
2024-11-20 13G MGNX / MacroGenics, Inc. 3,175,665
2024-11-07 13D/A KALV / KalVista Pharmaceuticals, Inc. 3,687,867 4,887,867
2024-11-06 13G/A TRVI / Trevi Therapeutics, Inc. 6,663,590 7,381,090
2024-11-05 13G ELDN / Eledon Pharmaceuticals, Inc. 3,561,644
2024-09-23 13D MBX / MBX Biosciences, Inc. 5,985,347
2024-08-22 13D/A PHAT / Phathom Pharmaceuticals, Inc. 10,169,788 12,788,710
2024-07-15 13G/A ELEV / Elevation Oncology, Inc. 2,958,579 5,993,579
2024-06-25 13G IRON / Disc Medicine, Inc. 1,754,834
2024-06-06 13D/A PHAT / Phathom Pharmaceuticals, Inc. 10,125,788 10,169,788
2024-05-31 13D/A HLVX / HilleVax, Inc. 9,806,472 10,639,562
2024-05-29 13G ERAS / Erasca, Inc. 16,216,216
2024-05-06 13G ANAB / AnaptysBio, Inc. 1,917,191
2024-04-10 13G / AN2 THERAPEUTICS 1,488,889
2024-04-09 13G ELEV / Elevation Oncology, Inc. 2,958,579
2024-03-29 13G PBYI / Puma Biotechnology, Inc. 2,631,713
2024-02-22 13D/A KALV / KalVista Pharmaceuticals, Inc. 3,582,294 3,687,867
2024-02-13 13G/A GRTSQ / Gritstone bio, Inc. 5,223,655 1,092,185
2024-02-13 13G/A INVA / Innoviva, Inc. 2,248,194 0
2024-02-09 13G ADVM / Adverum Biotechnologies, Inc. 10,416,666
2024-01-25 13G ORIC / ORIC Pharmaceuticals, Inc. 4,142,855
2023-12-14 13D/A KALV / KalVista Pharmaceuticals, Inc. 3,238,859 3,582,294
2023-10-05 13G/A SNDX / Syndax Pharmaceuticals, Inc. 3,708,838 0
2023-09-27 13D/A HLVX / HilleVax, Inc. 9,781,472 9,806,472
2023-05-26 13D/A PHAT / Phathom Pharmaceuticals, Inc. 8,428,105 10,125,788
2023-05-05 13D/A PHAT / Phathom Pharmaceuticals, Inc. 8,428,105
2023-05-05 13D/A HLVX / HilleVax, Inc. 9,637,232 9,781,472
2023-04-17 13G/A ALLK / Allakos Inc. 4,792,000 392,269
2023-02-14 13G/A COGT / Cogent Biosciences, Inc. 2,188,004 2,109,154
2023-02-14 13G/A TCDA / Tricida Inc 3,582,093 1,500,000
2023-02-14 13G/A SNDX / Syndax Pharmaceuticals, Inc. 2,772,062 3,708,838
2023-02-14 13G/A AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 3,730,657 3,746,857
2023-02-14 13G/A GRTSQ / Gritstone bio, Inc. 4,728,551 5,223,655
2023-02-14 13G/A KDNY / Chinook Therapeutics Inc 2,770,026 4,052,510
2023-02-14 13G/A GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock) 17,104,865 0
2023-02-14 13G/A ALLK / Allakos Inc. 2,900,000 4,792,000
2023-01-23 13G INVA / Innoviva, Inc. 2,248,194
2022-12-30 13D/A KALV / KalVista Pharmaceuticals, Inc. 1,572,192 3,238,859
2022-10-07 13G/A TRVI / Trevi Therapeutics, Inc. 3,816,459 6,663,590
2022-09-12 13G ALLK / Allakos Inc. 2,900,000
2022-09-08 13D/A HLVX / HilleVax, Inc. 9,123,572 9,637,232
2022-08-12 13G/A VRDN / Viridian Therapeutics, Inc. 1,505,200 300,000
2022-05-16 13G TCDA / Tricida Inc 3,582,093
2022-05-06 13D HLVX / HilleVax, Inc. 9,123,572
2022-04-29 13G KDNY / Chinook Therapeutics Inc 2,770,026
2022-04-18 13G TRVI / Trevi Therapeutics, Inc. 3,816,459
2022-03-29 13G/A SRRA / Sierra Oncology Inc 804,667 2,366,853
2022-03-17 13G GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock) 17,104,865
2022-03-01 13G COGT / Cogent Biosciences, Inc. 2,188,004
2022-01-31 13D/A KALV / KalVista Pharmaceuticals, Inc. 1,268,729 1,572,192
2022-01-28 13G/A PRDS / Pardes Biosciences Inc 1,113,700 2,457,507
2022-01-28 13G/A VRDN / Viridian Therapeutics, Inc. 1,305,200 1,505,200
2021-12-30 13D KALV / KalVista Pharmaceuticals, Inc. 1,268,729
2021-12-23 13G SNDX / Syndax Pharmaceuticals, Inc. 2,772,062
2021-12-17 13G AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 3,730,657
2021-12-17 13G PRDS / Pardes Biosciences Inc 1,113,700
2021-09-21 13G GRTS / Gritstone bio, Inc. 4,728,551
2021-08-26 13G VRDN / Viridian Therapeutics, Inc. 1,305,200
2021-08-16 13G SRRA / Sierra Oncology Inc 804,667